Jim Simons Nexgel, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Nexgel, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 81,631 shares of NXGL stock, worth $214,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,631

Previous 158,331 48.44%

Holding current value

$214,689

Previous $699,000 65.24%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$2.7 - $4.1 $207,090 - $314,470	-76,700 Reduced 48.44%	81,631 $243,000
Q4 2024 Feb 13, 2025	BUY	$2.4 - $4.93 $311,702 - $640,288	129,876 Added 456.43%	158,331 $699,000
Q3 2024 Nov 13, 2024	BUY	$2.04 - $3.19 $5,352 - $8,370	2,624 Added 10.16%	28,455 $73,000
Q2 2024 Aug 09, 2024	BUY	$2.06 - $2.38 $412 - $476	200 Added 0.78%	25,831 $55,000
Q1 2024 May 13, 2024	BUY	$1.99 - $2.96 $398 - $592	200 Added 0.79%	25,631 $70,000
Q4 2023 Feb 13, 2024	BUY	$1.5 - $2.35 $600 - $940	400 Added 1.6%	25,431 $54,000
Q3 2023 Nov 14, 2023	SELL	$1.75 - $2.52 $1,750 - $2,520	-1,000 Reduced 3.84%	25,031 $53,000
Q2 2023 Aug 11, 2023	BUY	$1.38 - $2.92 $7,727 - $16,352	5,600 Added 27.41%	26,031 $65,000
Q1 2023 May 12, 2023	BUY	$1.28 - $1.71 $896 - $1,197	700 Added 3.55%	20,431 $26,000
Q4 2022 Feb 13, 2023	SELL	$1.17 - $1.66 $1,287 - $1,826	-1,100 Reduced 5.28%	19,731 $25,000
Q3 2022 Nov 14, 2022	BUY	$0.25 - $1.98 $150 - $1,188	600 Added 2.97%	20,831 $31,000
Q2 2022 Aug 12, 2022	BUY	$1.4 - $1.98 $28,323 - $40,057	20,231 New	20,231 $34,000

Others Institutions Holding NXGL

# of Institutions

Shares Held

715K

Call Options Held

Put Options Held

View Full List

About NEXGEL, INC.

Ticker NXGL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 5,572,230
Market Cap $14.7M
Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...

More about NXGL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account